Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Preparing for epidemics now and in the future

Preparing for epidemics now and in the future

Mistrust and polarization steer rural governments to reject federal public health funding

Mistrust and polarization steer rural governments to reject federal public health funding

Scientists explore bat sarbecovirus isolation in Japan

Scientists explore bat sarbecovirus isolation in Japan

β-cyclodextrin family found to be promising and cost-effective antiviral agents against SARS-CoV-2

β-cyclodextrin family found to be promising and cost-effective antiviral agents against SARS-CoV-2

Bombali ebolavirus has been detected among bats in Mozambique

Bombali ebolavirus has been detected among bats in Mozambique

Intermediate levels of indoor relative humidity shown to improve COVID-19 outcomes globally

Intermediate levels of indoor relative humidity shown to improve COVID-19 outcomes globally

World Antimicrobial Awareness Week: Preventing Antimicrobial Resistance Together

World Antimicrobial Awareness Week: Preventing Antimicrobial Resistance Together

How gut microbes influence immune response to SARS-CoV-2

How gut microbes influence immune response to SARS-CoV-2

Study identifies risk factors and symptom clusters associated with long-COVID

Study identifies risk factors and symptom clusters associated with long-COVID

A heavy burden of family financial stress from COVID on mental health of adolescents

A heavy burden of family financial stress from COVID on mental health of adolescents

COVID-19 carries a much higher risk of epilepsy and seizures than influenza

COVID-19 carries a much higher risk of epilepsy and seizures than influenza

Bispecific antibodies neutralize Sarbecoviruses with increased breadth and potency

Bispecific antibodies neutralize Sarbecoviruses with increased breadth and potency

WHO releases new data on worldwide influenza activity

WHO releases new data on worldwide influenza activity

What is the immune protection generated by SARS-CoV-2 Delta and Omicron BA.1 and BA.2 against Omicron BA.4 and BA.5?

What is the immune protection generated by SARS-CoV-2 Delta and Omicron BA.1 and BA.2 against Omicron BA.4 and BA.5?

Evaluating differences in viral and symptom rebounds between Paxlovid-treated and untreated COVID-19 patients

Evaluating differences in viral and symptom rebounds between Paxlovid-treated and untreated COVID-19 patients

What is the prevalence of contraindications to Paxlovid among hospitalized COVID-19 patients?

What is the prevalence of contraindications to Paxlovid among hospitalized COVID-19 patients?

Study describes distinct pattern of ongoing respiratory syncytial virus transmission in the Netherlands after the COVID-19 pandemic

Study describes distinct pattern of ongoing respiratory syncytial virus transmission in the Netherlands after the COVID-19 pandemic

Comparing post–COVID-19 symptoms two years after SARS-CoV-2 infection

Comparing post–COVID-19 symptoms two years after SARS-CoV-2 infection

Protection afforded by SARS-CoV-2 infection against reinfection when Omicron BA.5 was the dominating subvariant in Scania county, Sweden

Protection afforded by SARS-CoV-2 infection against reinfection when Omicron BA.5 was the dominating subvariant in Scania county, Sweden

SARS-CoV-2 open reading frame 3c protein found to be targeted selectively to mitochondria

SARS-CoV-2 open reading frame 3c protein found to be targeted selectively to mitochondria

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.